跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
泽路泰 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Loncastuximab Tesirine For Injection
Approved
生物制品
Loncastuximab Tesirine For Injection
ADC Therapeutics
🇨🇳 National Medical Products Administration
Approval Date
Dec 6, 2024
Approval ID
8fOMGfHOm7v
Company
ADC Therapeutics
Type
生物制品
Approval Details
Approval Id
8fOMGfHOm7v
Approval Number
国药准字SJ20240046
Generic Name
注射用替朗妥昔单抗
Generic Name En
Loncastuximab Tesirine For Injection
Trade Name
泽路泰
Drug Type
生物制品
Dosage Form
注射剂
Strength
10mg/瓶
Reg Date
2024-12-06
Expired Date
2029-12-05
Company Name
ADC Therapeutics
Production Company Name
BSP PHARMACEUTICALS SPA
Company Detail Path
/organization/adc-therapeutics
Production Company Detail Path
/organization/bsp-pharmaceuticals-spa
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 6, 2024
Approval ID
8fOMGfHOm7v
Type
生物制品
Back to NMPA Approvals